 Glioblastoma multiforme, or GBM, may not sound familiar but if you suffer from this aggressive form of brain cancer the prognosis isnt good. Biopharmaceutical company CNS Pharmaceuticals Inc NASDAQ:CNSP, though, is looking to change that with its powerful chemotherapy drug Berubicin. 